Cosmo Technologies Limited, et al. v. Actavis Laboratories FL Inc., et al., C.A. Nos. 15-164-LPS; 15-193-LPS, September 7, 2016.
Stark, C. J. Claim construction opinion issues regarding seven terms from four patents. A Markman hearing took place on July 11, 2016.
The disputed technology relates to formulations containing budesonide, which are used to treat ulcerative colitis. The following terms were considered:
-
“matrix”
-
“macroscopically homogeneous composition" and "macroscopically homogeneous structure”
-
"outer hydrophilic matrix"
-
"lipophilic matrix"
-
"amphiphilic matrix"
-
"melting point"
-
"lipophilic/amphiphilic matrix"